# Teaching Note — Pablo Neruda pilot

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

## Why this case matters

This case shows how historical evidence can support a transparent fictional modern episode without presenting interpretation or generated content as documented fact.

## Learning objectives

1. Distinguish documented (**D**), retrospective (**R**), and synthetic (**S**) content.
2. Keep historical and active problems distinct.
3. Connect measurable goals and interventions to guidelines.
4. Preserve strengths, function, identity, and agency.

## Destigmatization message

A health condition is one part of a person’s life and does not erase achievement, relationships, purpose, or agency.

## Discussion questions

- Which facts support concern without establishing a modern diagnosis?
- Which entries belong in active problems, historical problems, or both?
- What additional evidence would change an evidence grade?
- How should an EHR distinguish synthetic and historical content?

## Evidence-grade summary

- **D:** Pablo Neruda was born on 12 July 1904 in the town of Parral in Chile. His father was a railway employee, and his mother, a teacher, died shortly after his birth; he spent his childhood and youth in Temuco. He used the pen name Pablo Neruda from 1920. The Nobel Prize biography gives his real name as Neftalí Ricardo Reyes Basoalto; the Library of the National Congress of Chile gives his birth name as Ricardo Eliecer Neftalí Reyes Basoalto and records that a court judgment of 28 December 1946 changed it to Pablo Neruda. Between 1927 and 1935 he held a series of honorary consulships in Burma, Ceylon, Java, Singapore, Buenos Aires, Barcelona and Madrid; in 1945 he was elected a senator of the Republic and joined the Communist Party of Chile. After the 1970 presidential election he was named Chile's ambassador to France; the Senate approved the appointment on 21 January 1971 and he presented his credentials at the end of that month. He resigned the post in 1972 and returned to Chile in November 1972. In July 1971 he began to have health problems and was operated on for prostate cancer; during his convalescence in France he wrote Geografía infructuosa. Later reports describe him as suffering from prostate cancer at the time of his death. The Nobel Prize in Literature was awarded to him on 21 October 1971, and he received it in Stockholm on 10 December 1971. He died on 23 September 1973 at the Clínica Santa María in Santiago, aged 69, twelve days after the military coup of 11 September 1973; he had been taken there by ambulance. The official cause of death was cancer cachexia: wasting from his prostate cancer. The National Library of Chile's account says he died of prostate cancer. His remains were exhumed in 2013. In November 2013 the head of Chile's medical legal service said that no relevant chemical substances had been found that could be linked to his death, and that experts had found traces of medicine used to treat cancer. In October 2017 an international panel of 16 forensic experts said it was certain he had not died of cancer cachexia, as the death certificate stated; one member said there was no indication of cachexia and that he was obese at the time of death. The panel said it could neither exclude nor affirm a natural or violent cause of death, and reported potentially deadly bacteria in a sample from one of his molars. In February 2023 laboratories in Canada and Denmark reported DNA of Clostridium botulinum in a molar and in bone fragments sampled in 2015. A member of the work said the finding was not definitive and did not tell what happened; panel members said they could not determine whether he had been poisoned or how the bacterium entered his body. In February 2024 the Santiago appeals court unanimously ordered the investigation into his death reopened, after a judge had declined to do so in December 2023; the death certificate lists cancer.
- **R:** Whether he died of his prostate cancer, of another natural cause such as an infection, or of poisoning is disputed and unresolved. The death certificate gives cancer cachexia; the 2013 tests found no relevant chemical substances; the 2017 panel rejected cachexia without naming a cause; the 2023 finding of Clostridium botulinum could not show how it got there; and the investigation was reopened in 2024.
- **S:** Shifted identity, fictional care team, modern encounters, results, plans, and outcomes.
